Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.

about

Enhanced oral absorption of pemetrexed by ion-pairing complex formation with deoxycholic acid derivative and multiple nanoemulsion formulations: preparation, characterization, and in vivo oral bioavailability and anticancer effect.

P2860

Q55248249-5545F4B7-12D4-4E63-B250-62907907C543

P2860

Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.

Item

http://www.wikidata.org/entity/Q38926514

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.

@en

type

Item

label

Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.

@en

prefLabel

Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.

@en

P1476

Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.

@en

P2093

Lauren Speciner

http://www.w3.org/2001/XMLSchema#string

Rebecca Carrier

http://www.w3.org/2001/XMLSchema#string

P2860

The use of modeling tools to drive efficient oral product design

Food-associated stimuli enhance barrier properties of gastrointestinal mucus

Identification of the major intestinal fatty acid transport protein

The Simcyp population-based ADME simulator

Microlymphatics and lymph flow

A century of dissolution research: From Noyes and Whitney to the Biopharmaceutics Classification System

Monitoring of in vitro fat digestion by electron paramagnetic resonance spectroscopy.

Prediction of intestinal absorption: comparative assessment of GASTROPLUS and IDEA.

Case studies for practical food effect assessments across BCS/BDDCS class compounds using in silico, in vitro, and preclinical in vivo data.

Quantitative prediction of formulation-specific food effects and their population variability from in vitro data with the physiologically-based ADAM model: a case study using the BCS/BDDCS Class II drug nifedipine.

P304

544-560

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JCONREL.2016.07.050

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

240

http://www.w3.org/2001/XMLSchema#string

P50

Oljora Rezhdo

P577

2016-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27520734

http://www.w3.org/2001/XMLSchema#string

P932

5082615

http://www.w3.org/2001/XMLSchema#string

Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.

about

P2860

P2860

Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P932